利培酮-话题@MedSci - 梅斯（MedSci）

#利培酮#

6篇内容 | 1272人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1530874, encodeId=cc3515308e480, content=<a href='/topic/show?id=7d4b322e4a0' target=_blank style='color:#2F92EE;'>#利培酮#</a>, objectTitle=精神分裂症案例解读 | 利培酮换药鲁拉西酮治疗青年精神分裂症病例, objectType=article, longId=292583, objectId=b07a29258312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b07a29258312, replyNumber=0, likeNumber=105, createdTime=2021-12-24, rootId=0, userName=chenshujs, userId=988c12173937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b07a29258312, moduleTitle=精神分裂症案例解读 | 利培酮换药鲁拉西酮治疗青年精神分裂症病例, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b07a29258312)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530873, encodeId=acf715308e361, content=<a href='/topic/show?id=7d4b322e4a0' target=_blank style='color:#2F92EE;'>#利培酮#</a>, objectTitle=FDA批准PERSERIS（利培酮）延长释放悬浮液治疗成人精神分裂症, objectType=article, longId=145540, objectId=3f6e145540e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f6e145540e6, replyNumber=0, likeNumber=119, createdTime=2018-08-01, rootId=0, userName=chenshujs, userId=988c12173937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f6e145540e6, moduleTitle=FDA批准PERSERIS（利培酮）延长释放悬浮液治疗成人精神分裂症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3f6e145540e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530872, encodeId=17ec15308e2b3, content=<a href='/topic/show?id=7d4b322e4a0' target=_blank style='color:#2F92EE;'>#利培酮#</a>, objectTitle=绿叶制药利培酮微球开发进展顺利中美上市申报跨越专利障碍, objectType=article, longId=121303, objectId=eb9112130355, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb9112130355, replyNumber=0, likeNumber=94, createdTime=2017-11-26, rootId=0, userName=chenshujs, userId=988c12173937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb9112130355, moduleTitle=绿叶制药利培酮微球开发进展顺利中美上市申报跨越专利障碍, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=eb9112130355)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530871, encodeId=ecad15308e1b3, content=<a href='/topic/show?id=7d4b322e4a0' target=_blank style='color:#2F92EE;'>#利培酮#</a>, objectTitle=LANCET：卡利拉嗪与利培酮单药治疗精神分裂症患者阴性症状的比较, objectType=article, longId=88925, objectId=f51588925b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f51588925b5, replyNumber=0, likeNumber=106, createdTime=2017-02-16, rootId=0, userName=chenshujs, userId=988c12173937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f51588925b5, moduleTitle=LANCET：卡利拉嗪与利培酮单药治疗精神分裂症患者阴性症状的比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f51588925b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530870, encodeId=f9d815308e061, content=<a href='/topic/show?id=7d4b322e4a0' target=_blank style='color:#2F92EE;'>#利培酮#</a>, objectTitle=JAMA Intern Med：姑息治疗中，利培酮或氟哌啶醇不能改善谵妄症状, objectType=article, longId=83976, objectId=04b5839e6a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04b5839e6a9, replyNumber=0, likeNumber=86, createdTime=2016-12-12, rootId=0, userName=chenshujs, userId=988c12173937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04b5839e6a9, moduleTitle=JAMA Intern Med：姑息治疗中，利培酮或氟哌啶醇不能改善谵妄症状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=04b5839e6a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530869, encodeId=20231530869e6, content=<a href='/topic/show?id=7d4b322e4a0' target=_blank style='color:#2F92EE;'>#利培酮#</a>, objectTitle=阿尔茨海默病患者停用利培酮后精神症状易复发, objectType=article, longId=8746, objectId=3cf38e4696, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cf38e4696, replyNumber=0, likeNumber=85, createdTime=2012-08-11, rootId=0, userName=chenshujs, userId=988c12173937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cf38e4696, moduleTitle=阿尔茨海默病患者停用利培酮后精神症状易复发, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3cf38e4696)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

利培酮

2020-05-29

chenshujs (审核中...)

前往app查看评论内容

#利培酮#

精神分裂症案例解读 | 利培酮换药鲁拉西酮治疗青年精神分裂症病例

2021-12-24

chenshujs (审核中...)

前往app查看评论内容

#利培酮#

FDA批准PERSERIS（利培酮）延长释放悬浮液治疗成人精神分裂症

2018-08-01

chenshujs (审核中...)

前往app查看评论内容

#利培酮#

绿叶制药利培酮微球开发进展顺利中美上市申报跨越专利障碍

2017-11-26

chenshujs (审核中...)

前往app查看评论内容

#利培酮#

LANCET：卡利拉嗪与利培酮单药治疗精神分裂症患者阴性症状的比较

2017-02-16

chenshujs (审核中...)

前往app查看评论内容

#利培酮#

JAMA Intern Med：姑息治疗中，利培酮或氟哌啶醇不能改善谵妄症状

2016-12-12

chenshujs (审核中...)

前往app查看评论内容

#利培酮#

阿尔茨海默病患者停用利培酮后精神症状易复发

2012-08-11

科室
- - 订阅+
  - 更多科室
工具
服务